本综述系统阐述了CRISPR/Cas9及其衍生技术碱基编辑（Base Editing）和引导编辑（Prime Editing）在植物性状改良中的突破性进展 ...

首次发现并定义了连接转座子与 CRISPR 之间长期缺失的关键进化中间体，将其命名为——TranC（Transposon-CRISPR intermediate）。 CRISPR-Cas 系统是原核生物的获得性免疫系统，能够在 CRISPR RNA 的指导下特异性切割入侵的外源核酸。其中，分别以 Cas9 和 Cas12 为效应蛋白的 ...

The study combines a deep learning model with CRISPR screens to control the expression of human genes in different ways -- such as flicking a light switch to shut them off completely or by using a ...

The practice of genetic modification is as old as humanity. For thousands of years, humans have bred crops, livestock and even pets that possess desirable traits. This selective process, which alters ...

CRISPR has the power to correct genetic mutations, but current delivery methods are either unsafe or inefficient, keeping the technology from reaching its full medical potential. With the power to ...

When the genome-editing tool CRISPR is thought of as a potential medicine, the targets that first come to mind are diseases like sickle cell or other conditions caused by particular mutations. Use ...

Researchers are further improving CRISPR's versatility to engineer new grasses and yeasts for biochemical production. CRISPR/Cas systems have undergone tremendous advancement in the past decade. These ...

CRISPR Therapeutics (CRSP) just announced that its SyNTase gene editing technology will be featured in an oral presentation at the ESGCT 2025 Congress. This marks the first major public unveiling of ...

Gene editing techniques may eventually allow trisomy to be treated at the cellular level, according to an in vitro proof-of-concept study. Down syndrome is caused by the presence of a third copy of ...